• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明细胞肾细胞癌中的 microRNA 表达谱分析:关键 microRNA 的鉴定与功能验证

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.

作者信息

He Haowei, Wang Linhui, Zhou Wenquan, Zhang Zhengyu, Wang Longxin, Xu Song, Wang Dong, Dong Jie, Tang Chaopeng, Tang Hao, Yi Xiaoming, Ge Jingping

机构信息

Department of Urology, Jinling Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.

Department of Urology, Changzheng Hospital, Second Military Medical University, Shanghai, Shanghai, China.

出版信息

PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.

DOI:10.1371/journal.pone.0125672
PMID:25938468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4418764/
Abstract

OBJECTIVE

This study aims to profile dysregulated microRNA (miRNA) expression in clear cell renal cell carcinoma (ccRCC) and to identify key regulatory miRNAs in ccRCC.

METHODS AND RESULTS

miRNA expression profiles in nine pairs of ccRCC tumor samples at three different stages and the adjacent, non-tumorous tissues were investigated using miRNA arrays. Eleven miRNAs were identified to be commonly dysregulated, including three up-regulated (miR-487a, miR-491-3p and miR-452) and eight down-regulated (miR-125b, miR-142-3p, miR-199a-5p, miR-22, miR-299-3p, miR-29a, miR-429, and miR-532-5p) in tumor tissues as compared with adjacent normal tissues. The 11 miRNAs and their predicted target genes were analyzed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and three key miRNAs (miR-199a-5p, miR-22 and miR-429) were identified by microRNA-gene network analysis. Dysregulation of the three key miRNAs were further validated in another cohort of 15 ccRCC samples, and the human kidney carcinoma cell line 786-O, as compared with five normal kidney samples. Further investigation showed that over-expression of miR-199a-5p significantly inhibited the invasion ability of 786-O cells. Luciferase reporter assays indicated that miR-199a-5p regulated expression of TGFBR1 and JunB by directly interacting with their 3' untranslated regions. Transfection of miR-199a-5p successfully suppressed expression of TGFBR1 and JunB in the human embryonic kidney 293T cells, further confirming the direct regulation of miR-199a-5p on these two genes.

CONCLUSIONS

This study identified 11 commonly dysregulated miRNAs in ccRCC, three of which (miR-199a-5p, miR-22 and miR-429) may represent key miRNAs involved in the pathogenesis of ccRCC. Further studies suggested that miR-199a-5p plays an important role in inhibition of cell invasion of ccRCC cells by suppressing expression of TGFBR1 and JunB.

摘要

目的

本研究旨在分析透明细胞肾细胞癌(ccRCC)中失调的微小RNA(miRNA)表达谱,并鉴定ccRCC中的关键调控miRNA。

方法与结果

使用miRNA芯片研究了9对处于三个不同阶段的ccRCC肿瘤样本及其相邻的非肿瘤组织中的miRNA表达谱。鉴定出11种miRNA普遍失调,与相邻正常组织相比,肿瘤组织中有3种上调(miR-487a、miR-491-3p和miR-452),8种下调(miR-125b、miR-142-3p、miR-199a-5p、miR-22、miR-299-3p、miR-29a、miR-429和miR-532-5p)。通过基因本体论和京都基因与基因组百科全书(KEGG)通路富集分析对这11种miRNA及其预测的靶基因进行了分析,并通过miRNA-基因网络分析鉴定出3种关键miRNA(miR-199a-5p、miR-22和miR-429)。在另一组15个ccRCC样本以及人肾癌细胞系786-O中,与5个正常肾样本相比,进一步验证了这3种关键miRNA的失调情况。进一步研究表明,miR-199a-5p的过表达显著抑制了786-O细胞的侵袭能力。荧光素酶报告基因检测表明,miR-199a-5p通过直接与其3'非翻译区相互作用来调节TGFBR1和JunB的表达。在人胚肾293T细胞中,转染miR-199a-5p成功抑制了TGFBR1和JunB的表达,进一步证实了miR-199a-5p对这两个基因的直接调控作用。

结论

本研究鉴定出ccRCC中11种普遍失调的miRNA,其中3种(miR-199a-5p、miR-22和miR-429)可能是参与ccRCC发病机制的关键miRNA。进一步研究表明,miR-199a-5p通过抑制TGFBR1和JunB的表达,在抑制ccRCC细胞的侵袭中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/2d81dbce9cf5/pone.0125672.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/489b68419b33/pone.0125672.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/1eb23d72815a/pone.0125672.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/51a7a2e329a1/pone.0125672.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/22ab615dca8c/pone.0125672.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/2d81dbce9cf5/pone.0125672.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/489b68419b33/pone.0125672.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/1eb23d72815a/pone.0125672.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/51a7a2e329a1/pone.0125672.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/22ab615dca8c/pone.0125672.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a318/4418764/2d81dbce9cf5/pone.0125672.g005.jpg

相似文献

1
MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.透明细胞肾细胞癌中的 microRNA 表达谱分析:关键 microRNA 的鉴定与功能验证
PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.
2
MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.miRNA 谱分析揭示骨化性纤维瘤中失调的 microRNAs 及其靶基因调控网络。
J Oral Pathol Med. 2018 Jan;47(1):78-85. doi: 10.1111/jop.12650. Epub 2017 Nov 1.
3
Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.基于miRNA测序和数字基因表达测序数据的透明细胞肾细胞癌生物标志物鉴定
Gene. 2018 Mar 20;647:205-212. doi: 10.1016/j.gene.2017.12.031. Epub 2017 Dec 15.
4
Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.miR-149 的双链通过靶向肾细胞癌中的 FOXM1 抑制癌细胞迁移和侵袭。
Int J Mol Sci. 2017 Sep 13;18(9):1969. doi: 10.3390/ijms18091969.
5
MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity.透明细胞肾细胞癌组织中的微小RNA分析可能将肿瘤发生和复发与肥胖联系起来。
Br J Cancer. 2017 Jan 3;116(1):77-84. doi: 10.1038/bjc.2016.392. Epub 2016 Dec 1.
6
Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.miR-141-3p与miR-145-5p在透明细胞肾细胞癌靶标调控中的协同作用
PLoS One. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801. eCollection 2016.
7
Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.以miR-146-5p为例的与局限性透明细胞肾细胞癌向转移性透明细胞肾细胞癌转变相关的整合微小RNA和信使核糖核酸特征
PLoS One. 2016 Feb 9;11(2):e0148746. doi: 10.1371/journal.pone.0148746. eCollection 2016.
8
Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.miR-27a-3p的表达是透明细胞肾细胞癌复发的独立预测因素。
Oncotarget. 2015 Aug 28;6(25):21645-54. doi: 10.18632/oncotarget.4064.
9
Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌中致癌性微小RNA的特征分析
Int J Mol Sci. 2015 Dec 8;16(12):29219-25. doi: 10.3390/ijms161226160.
10
miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma.微小RNA-200c靶向细胞周期蛋白依赖性激酶2并抑制肾细胞癌的肿瘤发生。
Mol Cancer Res. 2015 Dec;13(12):1567-77. doi: 10.1158/1541-7786.MCR-15-0128. Epub 2015 Aug 6.

引用本文的文献

1
MicroRNA-452: a double-edged sword in multiple human cancers.微小 RNA-452:多种人类癌症中的双刃剑。
Clin Transl Oncol. 2023 May;25(5):1189-1206. doi: 10.1007/s12094-022-03041-0. Epub 2023 Jan 9.
2
Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programs.泛癌症 mRNA 稳定性分析,用于解码肿瘤转录后程序。
Commun Biol. 2022 Aug 20;5(1):851. doi: 10.1038/s42003-022-03796-w.
3
Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.

本文引用的文献

1
MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma.微小RNA-133a抑制非小细胞肺癌中的多种致癌膜受体和细胞侵袭。
PLoS One. 2014 May 9;9(5):e96765. doi: 10.1371/journal.pone.0096765. eCollection 2014.
2
MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.miR-142-3p 通过靶向结肠癌细胞中的 CD133、ABCG2 和 Lgr5 发挥肿瘤抑制作用。
J Mol Med (Berl). 2013 Aug;91(8):989-1000. doi: 10.1007/s00109-013-1037-x. Epub 2013 Apr 26.
3
MiRNA-429 suppresses the growth of gastric cancer cells in vitro.
循环 microRNAs 从分子机制到临床生物标志物:以透明细胞肾细胞癌为例。
Genes (Basel). 2021 Jul 28;12(8):1154. doi: 10.3390/genes12081154.
4
MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma.miR-125b 通过靶向维生素 D 受体促进肾细胞癌的迁移和侵袭。
Int J Med Sci. 2021 Jan 1;18(1):150-156. doi: 10.7150/ijms.49328. eCollection 2021.
5
MicroRNA Signature in Renal Cell Carcinoma.肾细胞癌中的微小RNA特征
Front Oncol. 2020 Nov 30;10:596359. doi: 10.3389/fonc.2020.596359. eCollection 2020.
6
The miR-199a/214 Cluster Controls Nephrogenesis and Vascularization in a Human Embryonic Stem Cell Model.miR-199a/214 簇在人胚胎干细胞模型中控制肾发生和血管生成。
Stem Cell Reports. 2021 Jan 12;16(1):134-148. doi: 10.1016/j.stemcr.2020.11.007. Epub 2020 Dec 10.
7
MiR-125b-2-3p associates with prognosis of ccRCC through promoting tumor metastasis via targeting EGR1.MiR-125b-2-3p通过靶向EGR1促进肿瘤转移,与ccRCC的预后相关。
Am J Transl Res. 2020 Sep 15;12(9):5575-5585. eCollection 2020.
8
MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.MIR205HG 通过靶向 miR-299-3p/MAP3K2 轴促进肺鳞癌细胞增殖和进展。
BMC Pulm Med. 2020 Jun 8;20(1):163. doi: 10.1186/s12890-020-1174-2.
9
PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression.PGC1α 通过抑制胶原诱导的 SNAIL 表达抑制肾癌进展。
Matrix Biol. 2020 Jul;89:43-58. doi: 10.1016/j.matbio.2020.01.001. Epub 2020 Jan 23.
10
MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1.miRNA-532 通过靶向 CAMK2N1 在 t(4;14)多发性骨髓瘤中发挥致癌作用。
Hum Cell. 2019 Oct;32(4):529-539. doi: 10.1007/s13577-019-00276-y. Epub 2019 Aug 26.
微小RNA-429在体外抑制胃癌细胞的生长。
J Biomed Res. 2012 Sep;26(5):389-93. doi: 10.7555/JBR.26.20120029. Epub 2012 Sep 20.
4
miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.miR-22 在胃癌中表达下调,其过表达通过靶向转录因子 Sp1 抑制细胞迁移和侵袭。
Med Oncol. 2013 Jun;30(2):542. doi: 10.1007/s12032-013-0542-7. Epub 2013 Mar 26.
5
miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.miRNA-22 通过抑制 T 细胞淋巴瘤侵袭转移 1 和基质金属蛋白酶 2 和 9 的表达来抑制结肠癌细胞的迁移和侵袭。
Oncol Rep. 2013 May;29(5):1932-8. doi: 10.3892/or.2013.2300. Epub 2013 Feb 22.
6
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.miR-30d、miR-181a 和 miR-199a-5p 协同抑制癌症中的内质网伴侣和信号调节剂 GRP78。
Oncogene. 2013 Sep 26;32(39):4694-701. doi: 10.1038/onc.2012.483. Epub 2012 Oct 22.
7
Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关性肝细胞癌中失调 miRNA 及其靶基因的鉴定。
World J Gastroenterol. 2012 Oct 14;18(38):5442-53. doi: 10.3748/wjg.v18.i38.5442.
8
microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.microRNA-29a 通过靶向 SPARC 抑制肝癌细胞增殖。
Int J Mol Med. 2012 Dec;30(6):1321-6. doi: 10.3892/ijmm.2012.1140. Epub 2012 Sep 25.
9
Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.miR-29a 表达在儿童急性髓系白血病中的预后价值。
Clin Biochem. 2013 Jan;46(1-2):49-53. doi: 10.1016/j.clinbiochem.2012.09.002. Epub 2012 Sep 12.
10
The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.脱氧胆酸靶向 miRNA 依赖性 CAC1 基因表达调控人结直肠癌细胞多药耐药性
Int J Biochem Cell Biol. 2012 Dec;44(12):2321-32. doi: 10.1016/j.biocel.2012.08.006. Epub 2012 Aug 10.